Clinical Trial

Efficacy of Lactobacillus Paracasei LC19 on Type 2 Diabetes

Recruiting
View on ClinicalTrials.gov →
Summary
This is a randomized, double-blind, placebo-controlled clinical trial. The objective of this trial is to determine whether Lactobacillus paracasei LC19 supplementation has a positive effect on glucose lowering in patients with type 2 diabetes (T2D).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-10.
Status change: Not Yet Recruiting → Recruiting 2025-02-05
Trial Details
NCT Number NCT06639425
Lead Sponsor Beijing Chao Yang Hospital
Conditions Type 2 Diabetes
Enrollment 60 participants
Start Date 2024-10-12
Primary Completion 2026-10-14 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-07